Washington Trust Advisors, Inc. Dyne Therapeutics, Inc. Transaction History
Washington Trust Advisors, Inc.
- $1.15 Billion
- Q4 2024
A detailed history of Washington Trust Advisors, Inc. transactions in Dyne Therapeutics, Inc. stock. As of the latest transaction made, Washington Trust Advisors, Inc. holds 125 shares of DYN stock, worth $1,738. This represents 0.0% of its overall portfolio holdings.
Number of Shares
125
Previous 125
-0.0%
Holding current value
$1,738
Previous $4,000
50.0%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding DYN
# of Institutions
211Shares Held
101MCall Options Held
150KPut Options Held
297K-
Atlas Venture Life Science Advisors, LLC8.02MShares$112 Million31.16% of portfolio
-
Black Rock Inc. New York, NY7.39MShares$103 Million0.01% of portfolio
-
Janus Henderson Group PLC London, X07.38MShares$103 Million0.09% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.7MShares$93.3 Million0.0% of portfolio
-
Ra Capital Management, L.P. Boston, MA6.38MShares$88.8 Million2.43% of portfolio
About Dyne Therapeutics, Inc.
- Ticker DYN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 51,765,400
- Market Cap $720M
- Description
- Dyne Therapeutics, Inc., a muscle disease company, operates as a biotechnology company that focuses on advancing therapeutics for genetically driven muscle diseases in the United States. It develops various programs for myotonic dystrophy type 1, duchenne muscular dystrophy, and facioscapulohumeral dystrophy, as well as rare skeletal muscle, and...